Government
FemTech: Oova Launches New Fertility Membership Model
What You Should Know: Femtech solutions company OOVA launches its brand NEW fertility membership model designed to support and empower women by providing…
What You Should Know:
- Femtech solutions company OOVA launches its brand NEW fertility membership model designed to support and empower women by providing advanced at-home hormone testing and full-circle assistance along their fertility journey with unmatched ease, for only $99/mo.
- OOVA, the first and only OTC hormone test that quantitatively measures two essential hormones in a single, at-home urine test, provides women with insights into their ovulation patterns to increase the probability of conception.
The OOVA Fertility Membership
Only 1 in 10 women flow on a 28-day cycle, and monitoring + understanding your cycle patterns can take months and requires more than a single at-home test. Current at-home ovulation trackers operate on that baseline, consequently providing false-positive and futile results. OOVA is FDA-registered, HIPAA compliant, and the only test on the market to measure luteinizing hormone (LH) and progesterone (PdG) in real-time, providing women with daily insights and actionable advice to optimize their chances of conception.
The new OOVA fertility membership includes:
- Monthly supply of 15 test sticks
- Measuring 30 hormones with lab-quality accuracy
- Access to the OOVA provider network
- Experienced healthcare providers and 1:1 consultations with OOVA’s hormone experts to help you turn data into actionable insights
- Sync + share results with your doctor in real time
- The HIPAA compliant platform allows your doctor to access your hormone results virtually.
- The average doctor’s appointment is 6.5 minutes long. Coming to your appointment armed with data allows you to advocate for yourself and streamline your journey to conception.
- Support within the OOVA community + Monthly webinars
- Connect with other women on their own fertility journeys for a support system of people who understand infertility struggles.
Here Are the Champions! Our Top Performing Stories in 2023
It has been quite a year – not just for the psychedelic industry, but also for humanity as a whole. Volatile might not be the most elegant word for it,…
AI can already diagnose depression better than a doctor and tell you which treatment is best
Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting…
Scientists use organoid model to identify potential new pancreatic cancer treatment
A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer…
